scispace - formally typeset
K

Konstantinos Ritis

Researcher at Democritus University of Thrace

Publications -  100
Citations -  16641

Konstantinos Ritis is an academic researcher from Democritus University of Thrace. The author has contributed to research in topics: Neutrophil extracellular traps & Familial Mediterranean fever. The author has an hindex of 40, co-authored 91 publications receiving 12890 citations. Previous affiliations of Konstantinos Ritis include Umeå University.

Papers
More filters
Journal ArticleDOI

Identifying Patient Candidates for IL-1 Inhibition: Lessons From Real-World Cases

TL;DR: Five patients with difficult to treat gouty arthritis who were either candidates and/or treated with anti-IL therapy are described.
Journal Article

Rapid mutational analysis of N-ras proto-oncogene in hematologic malignancies: study of 77 Greek patient.

TL;DR: This reverse transcription-polymerase chain reaction (RT-PCR)/NIRCA protocol can allow the study of this proto-oncogene in every day clinical practice, rapidly facilitating the validation of the diagnostic and prognostic value of N-ras mutational analyses in patients with hematologic malignancies.
Journal ArticleDOI

Fast and reliable mutation detection of the complete exon 11-15 JAK2 coding region using non-isotopic RNase cleavage assay (NIRCA).

TL;DR: This work applied the non‐isotopic RNase cleavage assay to the screening for JAK2 V617F mutation in patients with polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis and confirmed the accuracy of the method, which can be applied in any laboratory without the requirement of specific sophisticated equipment.
Journal ArticleDOI

Multiple sclerosis in a patient with cryopyrin-associated autoinflammatory syndrome: Evidence that autoinflammation is the common link

TL;DR: In this article, the authors describe the case of a man with symptoms of cryopyrin-associated periodic syndrome (CAPS) since infancy who later developed multiple sclerosis (MS) and show that the inhibition of interleukin-1 (IL-1) with anakinra led to a swift resolution of the CAPS symptoms and also, in combination with teriflunomide, to a clinical and imaging improvement of MS.